All general enquiries including upcoming learning modules.
For questions about becoming a PCC member and PCC membership.
Submit a collaboration proposal for PCC’s consideration.
We have a number of virtual workshops planned with the dates to be released soon.
A selection of past events under the PCC umbrella.
Address challenges in precision oncology through collaboration.
Build relationships with precision oncology network to focus on increasing patient impact.
Contribute to improve patient outcomes through greater awareness and access to comprehensive genomic testing.
Leverage expertise and resources to share insights to address challenges in precision oncology.
Collaborate with independent third parties to address systemic care gaps.
Cost sharing to increase awareness and understanding to improve patient outcomes.
The PCC is a non-profit organization dedicated to driving global access to comprehensive genomic testing for all patients with cancer. The PCC is composed of and funded by: AstraZeneca, Bayer, GSK, Johnson & Johnson, Lilly, Novartis, and Roche, at the time of writing.
PCC-176, Date of Review: May 2025